FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000027513> ?p ?o ?g. }

• W2000027513 endingPage "60" @default.
• W2000027513 startingPage "50" @default.
• W2000027513 abstract "Fluorochrome-labeled inhibitors of caspases (FLICA, e.g., FAM-VAD-FMK, FITC-VAD-FMK) have been designed as affinity labels of the enzyme active center of caspases Their binding by apoptotic cells was interpreted as reflecting activation of caspases. We have recently observed, however, that their binding is more complex and may involve additional mechanisms. Our goal in this study was to clarify the ongoing utility of these probes.Apoptosis of HL-60, Jurkat, MCF-7 and T-24 cells was induced by the DNA topoisomerase I inhibitor, topotecan, or by oxidative stress (H(2)O(2)). Lymphocytes were induced by their mitogenic activation. Using multiparameter laser scanning and flow cytometry analysis, the correlation between FLICA binding and the number of known apoptotic indicators was examined. These included: collapse of the mitochondrial transmembrane potential; activation of caspase-3 (detected immunocytochemically); binding of annexin V; chromatin condensation; the presence of DNA strand breaks; and loss of plasma membrane capability to exclude propidium iodide (PI). FLICA binding specificity was tested by pretreatment with z-VAD-FMK or z-DEVD-FMK.FLICA binding was subsequent to the collapse of mitochondrial transmembrane potential, nearly concurrent with caspase-3 activation, and preceded annexin V binding, chromatin condensation, DNA fragmentation and loss of plasma membrane integrity. The predominant portion of FAM-VAD-FMK, FITC-VAD-FMK or FAM-DEVD-FMK binding to apoptotic cells could not be inhibited by z-VAD-FMK or z-DEVD-FMK, respectively, when the unlabeled inhibitors were added post-induction of apoptosis.FLICA are specific and convenient to use markers of apoptotic cells and they detect very early events of apoptosis associated with caspases activation. Assays that combine their binding with either the loss of mitochondrial potential or with exclusion of PI as a probe of plasma membrane integrity, distinguish sequential stages of apoptosis and are particularly useful to differentiate between apoptosis and necrosis. Our results conform with the published data that unlabeled caspase inhibitors, when added after induction of apoptosis, cannot prevent activation of caspases detected by binding of biotinylated inhibitors or by cleavage of fluorogenic substrates. While FLICA binding by apoptotic cells most likely is a consequence of caspase activation, these binding events may also involve other or additional mechanisms than simply their specific attachment to the active enzyme centers of caspases." @default.
• W2000027513 created "2016-06-24" @default.
• W2000027513 creator A5024359340 @default.
• W2000027513 creator A5044853892 @default.
• W2000027513 creator A5047612906 @default.
• W2000027513 creator A5056692511 @default.
• W2000027513 creator A5060701700 @default.
• W2000027513 creator A5086304089 @default.
• W2000027513 date "2003-08-18" @default.
• W2000027513 modified "2023-10-14" @default.
• W2000027513 title "Interactions of fluorochrome-labeled caspase inhibitors with apoptotic cells: A caution in data interpretation" @default.
• W2000027513 cites W1499834933 @default.
• W2000027513 cites W1967912613 @default.
• W2000027513 cites W1979188387 @default.
• W2000027513 cites W1979568748 @default.
• W2000027513 cites W1981106016 @default.
• W2000027513 cites W1984198719 @default.
• W2000027513 cites W1994659268 @default.
• W2000027513 cites W2008901624 @default.
• W2000027513 cites W2010298858 @default.
• W2000027513 cites W2013583594 @default.
• W2000027513 cites W2016721074 @default.
• W2000027513 cites W2019817345 @default.
• W2000027513 cites W2021516892 @default.
• W2000027513 cites W2022195980 @default.
• W2000027513 cites W2040554717 @default.
• W2000027513 cites W2045949658 @default.
• W2000027513 cites W2047409067 @default.
• W2000027513 cites W2048803904 @default.
• W2000027513 cites W2052804212 @default.
• W2000027513 cites W2054260525 @default.
• W2000027513 cites W2067461742 @default.
• W2000027513 cites W2081970496 @default.
• W2000027513 cites W2082717989 @default.
• W2000027513 cites W2086803177 @default.
• W2000027513 cites W2093504901 @default.
• W2000027513 cites W2109077371 @default.
• W2000027513 cites W2114499420 @default.
• W2000027513 cites W2121296375 @default.
• W2000027513 cites W2132712264 @default.
• W2000027513 cites W2135662322 @default.
• W2000027513 cites W2148911589 @default.
• W2000027513 cites W2151501496 @default.
• W2000027513 cites W2154049969 @default.
• W2000027513 cites W2156179144 @default.
• W2000027513 cites W2165436746 @default.
• W2000027513 cites W2166770635 @default.
• W2000027513 cites W2316240155 @default.
• W2000027513 cites W2334295856 @default.
• W2000027513 cites W4235863001 @default.
• W2000027513 cites W4240479615 @default.
• W2000027513 doi "https://doi.org/10.1002/cyto.a.10074" @default.
• W2000027513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12938188" @default.
• W2000027513 hasPublicationYear "2003" @default.
• W2000027513 type Work @default.
• W2000027513 sameAs 2000027513 @default.
• W2000027513 citedByCount "129" @default.
• W2000027513 countsByYear W20000275132012 @default.
• W2000027513 countsByYear W20000275132013 @default.
• W2000027513 countsByYear W20000275132014 @default.
• W2000027513 countsByYear W20000275132015 @default.
• W2000027513 countsByYear W20000275132016 @default.
• W2000027513 countsByYear W20000275132017 @default.
• W2000027513 countsByYear W20000275132018 @default.
• W2000027513 countsByYear W20000275132019 @default.
• W2000027513 countsByYear W20000275132020 @default.
• W2000027513 countsByYear W20000275132021 @default.
• W2000027513 countsByYear W20000275132023 @default.
• W2000027513 crossrefType "journal-article" @default.
• W2000027513 hasAuthorship W2000027513A5024359340 @default.
• W2000027513 hasAuthorship W2000027513A5044853892 @default.
• W2000027513 hasAuthorship W2000027513A5047612906 @default.
• W2000027513 hasAuthorship W2000027513A5056692511 @default.
• W2000027513 hasAuthorship W2000027513A5060701700 @default.
• W2000027513 hasAuthorship W2000027513A5086304089 @default.
• W2000027513 hasBestOaLocation W20000275131 @default.
• W2000027513 hasConcept C153911025 @default.
• W2000027513 hasConcept C179464577 @default.
• W2000027513 hasConcept C190283241 @default.
• W2000027513 hasConcept C203014093 @default.
• W2000027513 hasConcept C2775934118 @default.
• W2000027513 hasConcept C2776090121 @default.
• W2000027513 hasConcept C2778918659 @default.
• W2000027513 hasConcept C2779637612 @default.
• W2000027513 hasConcept C31573885 @default.
• W2000027513 hasConcept C41625074 @default.
• W2000027513 hasConcept C43759708 @default.
• W2000027513 hasConcept C553184892 @default.
• W2000027513 hasConcept C55493867 @default.
• W2000027513 hasConcept C86803240 @default.
• W2000027513 hasConcept C87439868 @default.
• W2000027513 hasConcept C88634738 @default.
• W2000027513 hasConcept C8891405 @default.
• W2000027513 hasConcept C95444343 @default.
• W2000027513 hasConcept C98424977 @default.
• W2000027513 hasConceptScore W2000027513C153911025 @default.
• W2000027513 hasConceptScore W2000027513C179464577 @default.
• W2000027513 hasConceptScore W2000027513C190283241 @default.

• next